Concepedia

Publication | Open Access

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma

28

Citations

39

References

2011

Year

Abstract

These data indicate that targeting PIM kinase signalling is a promising treatment strategy for RCC.

References

YearCitations

Page 1